INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2011

Clinical trials show resveratrol is safe and reasonably well-tolerated at doses up to 5 g/day, though mild to moderate side effects may limit dosing.

This review summarizes available clinical trial data on resveratrol, which have largely focused on characterizing its pharmacokinetics, metabolism, and safety. Recent studies evaluating multiple dosing found resveratrol to be safe and reasonably well-tolerated at doses of up to 5 g/day. However, the occurrence of mild to moderate side effects is likely to limit future trial doses to significantly less than 5 g/day.

Study type
Narrative review of clinical trials
Who was studied
Human participants in published clinical trials
What was measured
Pharmacokinetics, metabolism, safety, tolerability, and mechanisms of activity

THE PAPER

Clinical trials of resveratrol.

Patel KR, Scott E, Brown VA, Gescher AJ, Steward WP, Brown K. Ann N Y Acad Sci, 2011.

PubMed 21261655 ↗DOI 10.1111/j.1749-6632.2010.05853.x ↗

Nutrients & adequacyOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.